Scientific Advisory Team

The Scientific Advisory Team at Renovacor provides expert guidance on the development and strategic direction of AAV-based gene therapies targeting cardiovascular and CNS diseases caused by BAG3 gene variants. This team of highly skilled advisors collaborates closely with internal research and development teams to ensure that the scientific approaches taken are cutting-edge, feasible, and aligned with the latest advancements in the biotechnology field.